To support the survival and proliferation of cancer cells, increased glucose uptake is achieved through glucose transporter type 1 (GLUT-1) translocation to the membrane (17), which might account for the decrease in the FBG level in bladder cancer cases. Here, SLC2A1 is linked to urinary bladder carcinoma.